Pòster a #Docusalut: Prevalence and associated risk factors for MASLD in people living with HIV: highlighting metabolic syndrome components http://hdl.handle.net/20.500.13003/26329 @idisba.bsky.social @adrirr.bsky.social #PublicaSalutIB #EACS2025
The 11th #STEPS HIV Cure Community-led Workshop was held on 15 October 2025, in Paris, France at the #EACS2025 conference.
⤵️ This is a summary report from the workshop.
www.eatg.org/publications...
@eacsociety.bsky.social
El estudio PROTECT muestra que el chemsex es diverso y cambiante. No hay un solo perfil, pero sí necesidades distintas de prevención y cuidado. Escuchar estas diferencias es clave para una salud sexual sin estigma.
#Chemsex #EACS2025 #SaludSexual #ReducciónDeDaños #Kitsafe
#PublicaSalutIB Profesionales de Son Llàtzer, Son Espases e @idisba.bsky.social participaron en el 20th European AIDS Conference 2025 que se celebró en París https://f.mtr.cool/wgmnfxlizy @adrirr.bsky.social #EACS2025
#PublicaSalutIB Professionals de Son Llàtzer, Son Espases i @idisba.bsky.social varen participar en el 20th European AIDS Conference 2025 que es va celebrar a París https://f.mtr.cool/ezkpdorfek @adrirr.bsky.social #EACS2025
Una nueva pastilla diaria para el VIH podría simplificar tratamientos complejos: virus indetectable en más del 90% de los casos, pocas interacciones y buena tolerabilidad 💊
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
#LaNoticiadelDía #VIH #EACS2025
💊 El chemsex cambia en Europa: nuevas drogas, perfiles más jóvenes y mayor riesgo de VIH e ITS.
Expertos en #EACS2025 piden más educación sexual y servicios sin estigma.
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 www.gtt-vih.org/publicacione...
#LaNoticiadelDía #VIH #Chemsex
Las estatinas reducen el riesgo de infarto en personas con el #VIH 🩺
Aun así, su uso sigue por debajo de lo recomendado, según la #EACS2025.
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 www.gtt-vih.org/publicacione...
#LaNoticiadelDía #VIH #Estatinas
#EACS2025 Expertos piden mejorar el cribado del cáncer en personas con el VIH.
Los tumores pueden aparecer antes o ser más agresivos si el sistema inmunitario está débil.
La detección precoz salva vidas 💪
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
Eine Studie, die auf der jüngsten 20. Europäischen AIDS-Konferenz #EACS2025 vorgestellt wurde, hat ergeben, dass erhöhte #STI -Diagnosen, zumindest bei schwulen und bisexuellen Männern mit HIV in Frankreich, eher auf häufigere Tests als auf mehr Infektionen zurückzuführen ist.
“We are on our way to not a new normal but a new different in terms of how we have to finance healthcare in general”
Gus Cairns (United Kingdom) (EATG)
From #EACS2025 EATG Special Session
#EATGatEACS2025
@eacsociety.bsky.social
Chemsex patterns are changing across Europe - with implications for PrEP and HIV prevention.
An @aidsmap.bsky.social report from #EACS2025.
Las células NK podrían ser clave en la curación del VIH. El “segundo paciente de Berlín”, presentado en #EACS2025, muestra cómo el sistema inmunitario innato puede eliminar el virus 🧬
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
#LaNoticiadelDía #VIH
News from the 20th European AIDS Conference:
Chemsex use is changing in Europe
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/nov-202...
“Europe must lead through supporting European values: integration, support for public health and human rights, and cohesion”
Julia del Amo (Spain) (MoH - Division for the control of HIV, STI, VH and Tuberculosis)
From #EACS2025 EATG Special Session
#EATGatEACS2025
@eacsociety.bsky.social
News from the 20th European AIDS Conference:
Increased STI diagnoses in gay men with HIV are mainly due to more testing
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/nov-202...
Dos estudios (en Suiza y España) muestran que suspender el tratamiento con tenofovir casi nunca provoca la reactivación del virus de la hepatitis B en personas con el #VIH.
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
#HepatitisB #EACS2025
News from the 20th European AIDS Conference:
STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/nov-202...
News from the 20th European AIDS Conference:
Less weight gain with Dovato than Biktarvy
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/nov-202...
“We do have the potential to end the HIV epidemic, but we need more resources to do so”
Remko van Leeuwen (Aidsfonds )
#EACS2025 EATG Special Session | HIV and other communicable diseases amid permacrisis: can Europe lead the way?
#EATGatEACS2025
@eacsociety.bsky.social
@aidsfonds.bsky.social
Colourful i-Base graphic. The main text reads: EACS guidelines major update. Screening tools for sleep disorders now part of routine HIV care. At the top left is i-Base’s website address: I hyphen base dot info. The EACS 2025 logo is in the top right. At the bottom it says, read our full summary at the link. The colours used in the image are dark blue, mustard, red, orange, white and light blue.
#EACS #HIVguidelines major update: new focus on #sleep health.
This includes asking ‘How is your sleep?’ when starting #HIVtreatment, changing ART, or every two years.
More details in our guidelines summary:
i-base.info/htb/52581
#EACS2025 #HIV #HIVsky #HIVcare #insomnia @eacsociety.bsky.social
Statins reduce the risk of major cardiovascular events by 36% in people with HIV and are now recommended for all over 40 by the British HIV Association and other bodies - so why is take up so low?
An @aidsmap.bsky.social report from #EACS2025.
📢Now published!
The #EACS2025 #Scientific #News Bulletin is available in French, Spanish, Portuguese, Italian, and Russian.
Explore the full overview of scientific news from the 20th European #AIDS Conference.
https://ow.ly/IOz450Xkezq
Una pastilla semanal con lenacapavir e islatravir mantuvo el VIH indetectable en más del 94% de las personas tratadas 🧬
Más comodidad, misma eficacia 🙌🏼
📲 Lee «La Noticia del Día» de gTt-VIH 🧡
🔗 gtt-vih.org/publicacione...
#LaNoticiadelDía #VIH #EACS2025 #TratamientoVIH
Colourful i-Base graphic. The main text reads: On-demand PrEP with 2:1:1 or 2:7 dosing could help get Europe's HIV targets back on track. At the top is i-Base’s website address: I hyphen base dot info. At the bottom it says, subscribe by email. A smaller, tilted square graphic on the right, reads: HTB news. 2025. HIV treatment, prevention, access, and more. The colours used in the image are three shades of orange, dark turquoise, light blue, purple, bright pink, two shades of green, yellow, dark blue, mustard, red, and white.
Europe misses key #HIV targets but @eacsociety.bsky.social now recommends on-demand #PrEP for all with 2:1:1 or 2:7 dosing:
i-base.info/htb/52635
Removing the burden of daily pills for women & trans people makes #PrEPaccess more equitable & could improve low numbers in #Europe.
#EACS2025 #HIVsky
News from the 20th European AIDS Conference:
Tailored cancer screening strategies needed for people with HIV
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/oct-202...
News from the 20th European AIDS Conference:
Too few people with HIV receiving statins despite guideline changes
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/oct-202...
👉 Prostate cancer presents earlier and is more advanced in men with HIV.
👉 Women with a lower nadir CD4 count have greater risk of both anal and cervical cancer.
New studies on cancer and HIV presented at #EACS2025 suggest new screening strategies are needed.
News from the 20th European AIDS Conference:
Three ways Ukraine is using AI to improve HIV services
@eacsociety.bsky.social #EACS2025
www.aidsmap.com/news/oct-202...
Me (58 year old bloke, fairly well preserved) in a blue suit and deep red shirt, smiling, with moustache.
New portrait by Steven Doyle for his documentary series on people who live with HIV.
Photographed at #EACS2025.
View the full gallery at:
plhivdocumentary.com/participants...